KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) Shares Outstanding (Weighted Average) (2016 - 2026)

Encompass Health (EHC) has disclosed Shares Outstanding (Weighted Average) for 18 consecutive years, with $99.2 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 1.29% year-over-year to $99.2 million; the TTM value through Mar 2026 reached $99.2 million, down 1.29%, while the annual FY2025 figure was $100.5 million, 0.6% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $99.2 million in Q1 2026 for Encompass Health, down from $100.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $100.6 million in Q2 2025 and bottomed at $99.2 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $99.7 million, with a median of $99.5 million recorded in 2023.
  • Year-over-year, Shares Outstanding (Weighted Average) rose 0.7% in 2025 and then dropped 1.29% in 2026.
  • Encompass Health's Shares Outstanding (Weighted Average) stood at $99.2 million in 2022, then rose by 0.3% to $99.5 million in 2023, then rose by 0.4% to $99.9 million in 2024, then increased by 0.6% to $100.5 million in 2025, then dropped by 1.29% to $99.2 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $99.2 million, $100.5 million, and $100.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.